Skip to content 
Search

Latest Stories

UK cancer care crisis can lead to fatal outcomes warn experts

Patients may die due to the government’s decision to eliminate a dedicated plan aimed at addressing the disease

UK cancer care crisis can lead to fatal outcomes warn experts

In the UK, the state of cancer care has reached a critical point, and experts in the field are warning that patients may face fatal consequences due to the government's decision to eliminate a dedicated plan aimed at addressing the disease.

With waiting times for NHS cancer treatment hitting a record high, projections suggest an additional 2,000 cancer patients per week by 2040.


In a controversial move, the government abandoned its longstanding cancer plan in January, and instead incorporated it into a broader "major conditions strategy" covering various other significant diseases, The Guardian reported.

A report released in the Lancet Oncology on Wednesday (15), authored by 12 cancer experts, highlights the potential for increased fatalities resulting from this decision.

Professor Pat Price, an oncologist and visiting professor at Imperial College London, emphasised the gravity of the situation stating, "The dangerous reality is that cancer care in this country is fast becoming a monumental crisis, and there appears to be no realistic plan. A cancer plan is not just a strategy; it is a lifeline for the one in two of us that will get cancer."

Mark Lawler, a professor of digital health at Queen’s University Belfast and the chair of the International Cancer Benchmarking Partnership, stressed on the potential human cost of eliminating a dedicated cancer strategy.

As a co-author of the report, he expressed concern over the decision to abandon a specific national cancer control plan in favour of a broader major conditions strategy, deeming it an incomprehensible move that does not prioritise the well-being of individuals with cancer.

The report highlights recent research indicating that countries with dedicated cancer policies demonstrate superior five-year survival outcomes.

Denmark, which, 15 years ago, shared the bottom of the cancer league table with the UK, prioritised cancer as a health issue and implemented a dedicated cancer plan, resulting in substantial improvements in five-year survival for six out of seven cancers analysed.

Ireland too has experienced enhanced survival rates for lung, pancreas, oesophageal, and rectal cancer, attributing this progress to dedicated funding and the prioritisation of cancer in its national cancer control plan.

However, Northern Ireland and Wales have fallen significantly behind, and England has witnessed lower-than-expected improvements in colorectal and ovarian cancer.

The authors also criticised the decision to eliminate the National Cancer Research Institute, expressing concern about the detrimental impact this move will have on patients.

Recent international research has revealed that patients treated in research-active hospitals can experience up to 15% better outcomes compared to those in non-research settings. Lawler emphasised the necessity of cancer research for delivering contemporary cancer care.

Expressing frustration at the perceived lack of government action, the experts have crafted their own 10-point cancer plan, as part of the report.

Professor Price remarked on the incredulity of clinicians having to produce such a plan themselves instead of the government.

The proposed 10-point plan includes a well-funded national cancer control plan, the reinstatement and strengthening of the National Cancer Research Institute, improved screening programmes, targeted measures against alcohol consumption, tobacco, and obesity, a focus on the 62-day cancer target, integration of hospice care within the NHS, and increased investment in equipment and infrastructure.

Highlighting the significant challenge posed by outdated cancer treatment equipment, particularly in areas like radiotherapy, Price said without substantial investments in both personnel and modern treatment machines, the NHS would be unable to address the escalating waiting times for cancer treatment effectively.

Professor Richard Sullivan, a joint senior author and director of the Institute of Cancer Policy at King’s College London, expressed concern over the failure to implement specific and adequately funded cancer plans, coupled with a research agenda tailored for effectiveness.

He highlighted that this shortfall contributes to widening patient inequalities, burnout among healthcare staff, and suboptimal outcomes. Sullivan said that all the necessary components are available to address these issues but there is a need for “political will.”

In response, a spokesperson from the Department of Health and Social Care noted that cancer diagnoses at earlier stages have become more frequent, with improved survival rates across various cancer types. The spokesperson also highlighted the NHS's record in diagnosing and treating a substantial number of cancer patients over the past two years.

More For You

New Covid strain

Experts have raised concerns about the immune-evasive nature of the Stratus strain

iStock

New Covid strain Stratus spreads in UK with unusual hoarse voice symptom

Key points

  • A new Covid strain known as Stratus is spreading across the UK
  • The variant is marked by a distinctive symptom: a hoarse or raspy voice
  • Sub-variants XFG and XFG.3 now account for 30% of cases in England
  • Experts say there is no evidence of more severe disease
  • Lower immunity levels may make more people vulnerable to infection

Covid variant Stratus on the rise in the UK

A new strain of Covid-19, known as Stratus, is spreading across the UK and drawing attention for its unusual symptom — a hoarse or raspy voice. According to data from the UK Health Security Agency (UKHSA), Stratus and its two sub-variants, XFG and XFG.3, are responsible for around 30 per cent of Covid cases in England.

Of the two, XFG.3 is currently the more dominant. The UKHSA confirmed that monitoring of all circulating Covid-19 variants is ongoing as part of regular surveillance.

Keep ReadingShow less
Human brain continues forming neurons

Neurogenesis, the process by which new neurons form in the brain

iStock

Human brain continues forming neurons well into old age, study finds

Key points

  • New neurons continue forming in the brain’s hippocampus into old age
  • Study confirms presence of neural progenitor cells in adults
  • DNA carbon dating and single-nucleus RNA sequencing were used
  • Research shows variation in neuron production between individuals
  • Findings could aid treatments for neurodegenerative and psychiatric disorders

Human brain shows ongoing neuron formation into older age

A new study has confirmed that the human brain continues to produce new nerve cells well into late adulthood, challenging previous assumptions about age-related decline in neurogenesis. The findings, published in the journal Science, provide fresh insight into how adaptable the brain remains over a lifetime.

Neurogenesis, the process by which new neurons form in the brain, is known to occur in the hippocampus — a region involved in memory. While previous research has suggested that this process continues throughout life, there has been limited concrete evidence of the presence of neural progenitor cells in the adult brain.

Keep ReadingShow less
Kent County Show 2025

Sophie, Duchess of Edinburgh, who grew up in Brenchley

Getty Images

Kent County Show opens with royal visit from Duchess of Edinburgh

Key points:

  • Day one of the Kent County Show begins at Detling Showground near Maidstone
  • The Duchess of Edinburgh visits the event for the first time in 16 years
  • Organisers expect up to 70,000 visitors over the weekend
  • Farming and rural life are at the centre of the three-day programme
  • Highlights include live camel racing, equine sports, livestock displays and more

Kent County Show opens with royal visit

The Kent County Show returned to Detling near Maidstone on Friday, marking the start of a major three-day celebration of farming, food, and rural living. The event opened with a special visit from the Duchess of Edinburgh, who is attending for the first time in 16 years.

Sophie, Duchess of Edinburgh, who grew up in Brenchley near Tunbridge Wells and serves as patron of the Association of Show and Agricultural Organisations (ASAO), met with farmers, equine exhibitors, and local businesses on her tour of the showground.

Keep ReadingShow less
Sri Aurobindo

Heehs’s biography is grounded in extensive archival research across France, England, India and Israel

AMG

Sri Aurobindo and the rise of the Asian century

Dinesh Sharma

My friend and colleague, the American historian Peter Heehs, who has lived in Pondicherry, India, for decades, recently published a compelling new biography, The Mother: A Life of Sri Aurobindo’s Collaborator (2025). Heehs previously authored The Lives of Sri Aurobindo (2008), which remains one of the most balanced and scholarly accounts of Aurobindo’s life.

According to Heehs, most previous biographies of the Mother were written for devotees and relied on secondary sources, often presenting her as a divine incarnation without critical engagement. “Such biographies are fine for those who see the Mother as a divine being,” Heehs said, “but they can be off-putting for readers who simply want to understand her life – as an artist, writer, spiritual teacher, and founder of the Ashram and Auroville.”

Keep ReadingShow less
Tesco Scotch Egg recall

Tesco has issued an urgent product recall for two batches of Wall’s Scotch Eggs

Tesco

Tesco recalls Wall’s Scotch Eggs over salmonella contamination

Key points

  • Tesco and the Food Standards Agency (FSA) have issued an urgent recall for Wall’s Scotch Eggs.
  • Salmonella contamination has been confirmed in two batches with a use-by date of July 2, 2025.
  • Customers are advised not to eat the affected items and return them to any Tesco store for a full refund.
  • No other Wall’s products are affected by this recall.

Wall’s Scotch Eggs recalled due to salmonella risk

Tesco has issued an urgent product recall for two batches of Wall’s Scotch Eggs after salmonella contamination was confirmed. The Food Standards Agency (FSA) supported the decision and has advised customers to check their kitchens and dispose of or return the products immediately.

The recall applies specifically to Wall’s 2 Classic Scotch Eggs 226g and Wall’s The Classic Scotch Egg 113g, both with a use-by date of 2 July 2025. Customers who purchased either product are urged not to consume them due to the potential health risk.

Keep ReadingShow less